These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3878272)

  • 21. Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation.
    Kurokowa M; Lynch K; Podolsky DK
    Biochem Biophys Res Commun; 1987 Feb; 142(3):775-82. PubMed ID: 3548718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant responses to growth-regulatory signals by variant kidney epithelial cells.
    Walsh-Reitz MM; Feldman RI; Toback FG
    Am J Physiol; 1988 May; 254(5 Pt 2):F747-53. PubMed ID: 3364581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of growth inhibitory activity in transformed mouse embryo fibroblasts.
    Levine AE; Crandall CA; Brattain MG
    Exp Cell Res; 1987 Aug; 171(2):357-66. PubMed ID: 2887448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent transformed growth-inhibiting factor in human malignant effusions.
    Podolsky DK; Pleskow DK; Jafari H
    Cancer Res; 1988 Jan; 48(2):418-24. PubMed ID: 3257164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial tissue-derived growth factor-like polypeptides.
    Halper J; Moses HL
    Cancer Res; 1983 May; 43(5):1972-9. PubMed ID: 6572559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
    Levine AE; Crandall CA
    Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and properties of a type beta transforming growth factor from bovine kidney.
    Roberts AB; Anzano MA; Meyers CA; Wideman J; Blacher R; Pan YC; Stein S; Lehrman SR; Smith JM; Lamb LC
    Biochemistry; 1983 Dec; 22(25):5692-8. PubMed ID: 6607069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line.
    Johnston PG; Rondinone CM; Voeller D; Allegra CJ
    Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.
    Shipley GD; Pittelkow MR; Wille JJ; Scott RE; Moses HL
    Cancer Res; 1986 Apr; 46(4 Pt 2):2068-71. PubMed ID: 2418960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
    Anzano MA; Roberts AB; Smith JM; Sporn MB; De Larco JE
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6264-8. PubMed ID: 6604914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factors from a human tumor cell: characterization of transforming growth factor beta and identification of high molecular weight transforming growth factor alpha.
    Dart LL; Smith DM; Meyers CA; Sporn MB; Frolik CA
    Biochemistry; 1985 Oct; 24(21):5925-31. PubMed ID: 3002426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of sarcoma growth inhibitor from avian sarcoma virus-transformed rat cells.
    Yamaoka K; Hirai R; Hiragun A
    Jpn J Cancer Res; 1986 Apr; 77(4):319-23. PubMed ID: 3009374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
    Keski-Oja J; Lyons RM; Moses HL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.
    Dong F; Wu HB; Hong J; Rechler MM
    J Cell Physiol; 2002 Jan; 190(1):63-73. PubMed ID: 11807812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.
    Knabbe C; Lippman ME; Wakefield LM; Flanders KC; Kasid A; Derynck R; Dickson RB
    Cell; 1987 Feb; 48(3):417-28. PubMed ID: 2879636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.